Literature DB >> 33099950

MiR-505 inhibits prostate cancer cell invasion, metastasis and epithelial-to-mesenchymal transition through targeting HMGB-1.

Yakun Zhang1, Feifei Lv, Liang Qiao, Qiang Zhao.   

Abstract

PURPOSE: It has been proved that miR-505 expression was changed in prostate cancer (PC) tissues. However, its role and molecular mechanism in PC cells remains unclear. Our study aimed to study the microRNA (miR)-505 potential role and potential mechanism in PC cells.
METHODS: miR-505 and HMGB-1 expression in PC tissues and cells was measured by RT-PCR and western blot, respectively. MiR-505 mimic or inhibitor was applied to increase or decrease miR-505 expression in DU145 cells separately. Invaded cells and migrated cells were detected by transwell assay. Epithelial-mesenchymal transition (EMT) was evalauted using western blot. Moreover, Luciferase reporter assay was carried out to confirm miR-505's target gene.
RESULTS: miR-505 expression was declined while HMGB-1 expression was raised in PC tissues and cells. Furthermore, increasing miR-505 expression suppressed, whereas decreasing miR-505 expression promoted cell invasion, migration and EMT in DU145 cells. Moreover, miR-505 could target HMGB-1 in regulating PC progression. Knockdown of HMGB-1 inhibited cell invasion and migration and re-expression of HMGB-1 reversed miR-505 mimic inhibitory effect on PC cell invasion and migration.
CONCLUSION: We conclude that miR-505 suppressed cell invasion, metastasis and ETM through targeting HMGB-1, which provided a potential target for PC treatment.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33099950

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  2 in total

1.  The Clinical Significance and Functional Role of miR-466 in Gastric Cancer Peritoneal Metastasis.

Authors:  Yong Wang; Bo Yan; Lei Ni; Yunfei Si; Pingli Cao
Journal:  Mol Biotechnol       Date:  2021-08-25       Impact factor: 2.695

2.  circ‑LRP6 contributes to osteosarcoma progression by regulating the miR‑141‑3p/HDAC4/HMGB1 axis.

Authors:  Yali Yu; Guixiang Dong; Zijun Li; Yan Zheng; Zhisong Shi; Guanghui Wang
Journal:  Int J Oncol       Date:  2022-02-25       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.